T1	Disease	39 83	HER-2/neu ( HER2 ) overexpressing breast and
T2	Disease	84 103	ovarian cancers for
T3	Pharmacodynamic_phenotype	160 206	immunogenicity of a HER2 peptide vaccine based
T4	Phenotype	225 254	immune competence as assessed
T5	Chemical	292 302	antigens (
R1	isAssociatedWith	Arg1:T1	Arg2:T3
R2	isAssociatedWith	Arg1:T1	Arg2:T4
R3	isAssociatedWith	Arg1:T1	Arg2:T5
R4	isAssociatedWith	Arg1:T2	Arg2:T3
R5	isAssociatedWith	Arg1:T2	Arg2:T4
R6	isAssociatedWith	Arg1:T2	Arg2:T5
R7	influences	Arg1:T3	Arg2:T1
R8	influences	Arg1:T3	Arg2:T2
R9	influences	Arg1:T3	Arg2:T4
R10	influences	Arg1:T3	Arg2:T5
R11	influences	Arg1:T4	Arg2:T1
R12	influences	Arg1:T4	Arg2:T2
R13	isAssociatedWith	Arg1:T4	Arg2:T3
R14	influences	Arg1:T4	Arg2:T5
R15	isAssociatedWith	Arg1:T5	Arg2:T2
R16	isAssociatedWith	Arg1:T5	Arg2:T3
R17	isAssociatedWith	Arg1:T5	Arg2:T4
